Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Heal

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Neuropharmacology|March 1, 1980
The effects of iron deficiency on brain biogenic monoamine biochemistry and function in ratsM B Youdim, A R Green, M R Bloomfield, et al.
Neuropharmacology|November 1, 1988
The influence of injection of oestradiol to female rats on changes in alpha 2- and beta-adrenoceptor function induced by repeated administration of desipramine or electroconvulsive shockD J Heal, L J Bristow, R J De Souza, et al.
Psychopharmacology|January 1, 1992
A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramineD J Heal, A T Frankland, J Gosden, et al.
Synapse (New York, N.Y.)|October 6, 2000
Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving ratsH L Rowley, S A Butler, M R Prow, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2022
Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical DependenceR A Gray, D J Heal, D R Maguire, et al.
Neuropharmacology|June 14, 2024
Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuseFilomene G Morrison, Lori Jean Van Orden, Karla Zeitz, et al.
Drug and Alcohol Dependence|January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in ratsColleen Synan, Carrie Bowen, David J Heal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 13, 2004
Methamphetamine activates reward circuitry in drug naïve human subjectsBirgit A Völlm, Ivan E de Araujo, Philip J Cowen, et al.
The Journal of Biological Chemistry|June 18, 2016
Structural and Functional Analysis of Cell Wall-anchored Polypeptide Adhesin BspA in Streptococcus agalactiaeSara Rego, Timothy J Heal, Grace R Pidwill, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 15, 2011
Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channelsChristopher J Lynch, Qing Zhou, Show-Ling Shyng, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Neuropharmacology|March 1, 1980
The effects of iron deficiency on brain biogenic monoamine biochemistry and function in ratsM B Youdim, A R Green, M R Bloomfield, et al.
Neuropharmacology|November 1, 1988
The influence of injection of oestradiol to female rats on changes in alpha 2- and beta-adrenoceptor function induced by repeated administration of desipramine or electroconvulsive shockD J Heal, L J Bristow, R J De Souza, et al.
Psychopharmacology|January 1, 1992
A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramineD J Heal, A T Frankland, J Gosden, et al.
Synapse (New York, N.Y.)|October 6, 2000
Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving ratsH L Rowley, S A Butler, M R Prow, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2022
Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical DependenceR A Gray, D J Heal, D R Maguire, et al.
Neuropharmacology|June 14, 2024
Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuseFilomene G Morrison, Lori Jean Van Orden, Karla Zeitz, et al.
Drug and Alcohol Dependence|January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in ratsColleen Synan, Carrie Bowen, David J Heal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 13, 2004
Methamphetamine activates reward circuitry in drug naïve human subjectsBirgit A Völlm, Ivan E de Araujo, Philip J Cowen, et al.
The Journal of Biological Chemistry|June 18, 2016
Structural and Functional Analysis of Cell Wall-anchored Polypeptide Adhesin BspA in Streptococcus agalactiaeSara Rego, Timothy J Heal, Grace R Pidwill, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 15, 2011
Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channelsChristopher J Lynch, Qing Zhou, Show-Ling Shyng, et al.
Pageof 19